Company Filing History:
1 out of 12 
1 out of 10 Years Active: 2014
Title: Osvaldo Augusto Sant'Anna: Innovator in Immunogenical Complexes
Introduction
Osvaldo Augusto Sant'Anna is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of immunology through his innovative work on immunogenical complexes. His research focuses on enhancing the efficacy of vaccines by utilizing advanced materials.
Latest Patents
Sant'Anna holds a patent for an "Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica." This invention relates to a product known as the immunogenical complex, which comprises an adjuvant characterized by solid particles of highly ordered nanostructured mesoporous silica, preferably SBA-15 Silica, and various vaccinal antigens encapsulated within these adjuvants. The immunogenical complex allows for the safe, gradual, and extended presentation of antigens to lymphocytes, leading to improved immunological memory and increased immunogenicity. This innovation ensures effective immunological protection with reduced amounts of antigens and fewer vaccine doses.
Career Highlights
Throughout his career, Sant'Anna has worked with prominent companies, including Cristalia Produtos Químicos Farmacêuticos Ltda. and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). His work has significantly impacted the pharmaceutical industry, particularly in vaccine development and immunology.
Collaborations
Sant'Anna has collaborated with esteemed colleagues such as Ogari Pacheco and Lucildes Mercure. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Osvaldo Augusto Sant'Anna is a pioneering inventor whose work on immunogenical complexes has the potential to revolutionize vaccine efficacy and immunological protection. His contributions to the field are invaluable and continue to influence future research and development in immunology.